European Journal of Medicinal Chemistry p. 1135 - 1146 (2017)
Update date:2022-08-29
Topics:
Yuan, Zigao
Chen, Shaopeng
Chen, Changjun
Chen, Jiwei
Chen, Chengken
Dai, Qiuzi
Gao, Chunmei
Jiang, Yuyang
PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.
View MoreJiangsu Hualin Chemical Co.,Ltd
Contact:86-25-87787395
Address:jiangsu china
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Contact:86-551-63540590
Address:No 1388 Furong Rd., Hefei, Anhui, China
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Contact:+1-973-357-0577
Address:10 Taft Rd.
Doi:10.1080/00397911.2010.519848
(2011)Doi:10.1002/(SICI)1097-4601(1996)28:11<799::AID-KIN2>3.0.CO;2-I
(1996)Doi:10.1039/b922450e
(2010)Doi:10.1016/0022-4596(92)90048-Z
(1992)Doi:10.1016/j.cattod.2018.07.033
(2019)Doi:10.1093/geronb/57.2.P144
(1902)